BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12484241)

  • 1. NQO1 and mEH exon 4 (mEH4) gene polymorphisms, smoking and colorectal cancer risk.
    Mitrou P; Watson M; Bingham S; Stebbings WS; Speakman CT; Loktionov A
    IARC Sci Publ; 2002; 156():495-7. PubMed ID: 12484241
    [No Abstract]   [Full Text] [Related]  

  • 2. Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study.
    Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hankinson SE; Hunter DJ
    Carcinogenesis; 2004 Jul; 25(7):1211-8. PubMed ID: 14988221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
    van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
    Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.
    Mitrou PN; Watson MA; Loktionov AS; Cardwell C; Gunter MJ; Atkin WS; Macklin CP; Cecil T; Bishop DT; Primrose J; Bingham SA
    Carcinogenesis; 2007 Apr; 28(4):875-82. PubMed ID: 17082176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study.
    Tranah GJ; Chan AT; Giovannucci E; Ma J; Fuchs C; Hunter DJ
    Mol Carcinog; 2005 Sep; 44(1):21-30. PubMed ID: 15924351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
    Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
    Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer: role of polymorphisms in biotransformation enzymes.
    Sarmanová J; Sůsová S; Gut I; Mrhalová M; Kodet R; Adámek J; Roth Z; Soucek P
    Eur J Hum Genet; 2004 Oct; 12(10):848-54. PubMed ID: 15280903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake.
    Ulrich CM; Bigler J; Whitton JA; Bostick R; Fosdick L; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):875-82. PubMed ID: 11489754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.
    Huang WY; Chatterjee N; Chanock S; Dean M; Yeager M; Schoen RE; Hou LF; Berndt SI; Yadavalli S; Johnson CC; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):152-7. PubMed ID: 15668489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
    Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer.
    Takagi S; Kinouchi Y; Hiwatashi N; Hirai M; Suzuki S; Takahashi S; Negoro K; Obana N; Shimosegawa T
    Anticancer Res; 2002; 22(5):2749-52. PubMed ID: 12529991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India.
    Ihsan R; Chattopadhyay I; Phukan R; Mishra AK; Purkayastha J; Sharma J; Zomawia E; Verma Y; Mahanta J; Saxena S; Kapur S
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1456-62. PubMed ID: 20659238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
    Nisa H; Budhathoki S; Morita M; Toyomura K; Nagano J; Ohnaka K; Kono S; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
    Mol Carcinog; 2013 Aug; 52(8):619-26. PubMed ID: 22415791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.
    Kiss I; Orsós Z; Gombos K; Bogner B; Csejtei A; Tibold A; Varga Z; Pázsit E; Magda I; Zölyomi A; Ember I
    Anticancer Res; 2007; 27(4C):2931-7. PubMed ID: 17695473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.
    Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
    Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
    Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
    Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
    Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
    Alexandrie AK; Nyberg F; Warholm M; Rannug A
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.